Recent News and Articles on the Keywords: fda + drug + times  Related to the article below (Last Update: 12/1/2008)

 News results: Standard Version | Text Version | Image Version Results 1 - 10 of about 69,251 for fda drug times. (2.26 seconds) 
Recent
Archives
  • All dates
  • 2000s
  • 1995-97
  • 1992-94
  • 1988-91
  • 1985-87

 Sorted by relevance   Sort by date   Sort by date with duplicates included 
FDA Accepts Cell Therapeutics' Zevalin sBLA and Grants Priority Review
MarketWatch -
Priority review is granted by the FDA for a treatment that addresses a significant unmet medical need. A Prescription Drug User Fee Act (PDUFA) target date ...
Cell Therapeutics gets FDA priority review on drug CNNMoney.com
Spectrum Pharmaceuticals Announces ZEVALIN sBLA Granted Priority ... MarketWatch
all 32 news articles »  CTIC - SPPI - OTC:CMTX
FDA Approves Duramed's Synthetic Conjugated Estrogens-A Vaginal Cream
MarketWatch -
today announced that the US Food and Drug Administration (FDA) has approved its subsidiary Duramed Pharmaceuticals, Inc.'s New Drug Application (NDA) for ...

dBTechno
FDA Details Its Food Safety Campaign
New York Times, United States -
But in the agency?s report, a copy of which was provided to The New York Times, and in an interview with Dr. Acheson, the FDA maintains that its overhaul is ...
Exclusive: ?Made in China? ? Is It Time for This Label to Leave ... Family Security Matters
Demands For Baby Formula Recall Mount WHIOtv.com
FDA finds traces of melamine in US infant formula Alexandria Town Talk
San Francisco Chronicle - Fort Worth Star Telegram
all 89 news articles »
White Paper Addresses FDA Approval Challenges Facing Combination ...
MarketWatch -
According to the FDA, some estimate the total global value of the drug-device combination products market will grow to $11.5 billion in 2010, ...
Teva Grabs Billions Gambling on Copies of Brand Drugs (Update1)
Bloomberg -
The maker of the original drug can sue, claiming infringement, when a generic-drug company applies to the FDA to market copies. That triggers a 30-month ...TEVA
AstraZeneca's new lung drug may face US delay
IBTimes Hong Kong, CA -
It now plans to answer the FDA's questions before the end of the first half of the year, but it is unclear whether that will give the company enough time to ...
MedImmune to double size of its Gaithersburg HQ Washington Business Journal
all 6 news articles »  AZN
Doctors ditch drug samples to avoid influencing treatment
USA Today -
They found that the doctors were three times more likely to prescribe less-expensive generics to uninsured patients after they lost the samples closet. ...
Zapping depression
Philadelphia Inquirer, PA -
No incidents were reported in data on 10000 sessions submitted to the FDA. Neuronetics didn't seek approval to treat all major depression; ...

Sportsnet.ca
ARMSTRONG: STILL NO DRUG-TESTING PROGRAM
Cycling Weekly, UK -
Lance Armstrong has stated that his 'personal' drug-testing program will be in place by the time of his first race at the Tour Down Under in January - but ...
Contador unsure of Armstrong level Tehran Times
Armstrong plans to have program running by January The Associated Press
all 225 news articles »
Drug Trial Publication Bias and the FDA
ScienceBlogs - 34 minutes ago
Finally, nine out of 99 conclusions differed between the NDAs and the papers; each time, the published conclusion favored the test drug. ...
Source: Google News


 

Recent News and Articles on the Keywords: times + drug + morphine  Related to the article below (Last Update: 8/5/2008)

Fentanyl found in bust
Weatherford Democrat, TX -
Fowler said dealers are offering the drug as hospital-grade morphine, when it is actually 80 times more potent. ?They are peddling it out there as morphine ...
My brain on drugs
PR CannaZine (press release), UK - Aug 4, 2008
Morphine must really be a pain killer drug and if no pain, no affect. Stupid, I know, to experiment with this but experiment and perhaps closer to my Dad. ...

Telegraph.co.uk
Let poppies be grown for medicine: expert
The Gazette (Montreal), Canada - Jul 29, 2008
Zakhilwal is Canadian representative of the Senlis Council, a Paris-based organization which advocates licensing poppy production to make medical morphine. ...
Afghanistan's opium; Talking terrorism; Democracy and unity; The ... International Herald Tribune
Exclusive: A Modest Proposal for Afghanistan Family Security Matters
Afghans fight an addiction to heroin The National
all 403 news articles »

UMass Magazine Online
The Shaman?s Pharmacy
UMass Magazine Online, MA -
While it?s true that common drugs are derived from plants?such as the opiate morphine, made from poppies?our current drug laws do not allow medicinal plants ...
BioBlocks Forms International Drug Discovery Team, Representing a ...
MarketWatch - Jul 31, 2008
In this role, Dr. Wade managed interdisciplinary drug discovery teams, timelines, and project goals. During his time at Neurocrine he worked on lead ...
Mom: System, Doctors Facilitated Son's Prescription Drug Death
Tampa Tribune, FL - Aug 1, 2008
Three times as many people die from prescription drug overdoses in Florida as from all illicit drugs combined, state drug czar Bill Janes said. ...
'Your whole world is turned upside down'
Galena Gazette, IL -
Now he's frequently on morphine, oxycontin, opiates and an anti-anxiety drug, which make him forgetful and leave him too disoriented to drive. ...
Baby given 10 times the prescribed dosage of morphine
The Standard, Hong Kong - Jul 27, 2008
The overdosage was discovered 15 minutes later, with medics administering another drug to neutralize the morphine. A hospital authority spokesman said the ...
Hospital probe after morphine baby overdose The Standard
all 3 news articles »
Nurse jailed for raping female patient
NEWS.com.au, Australia - Jul 27, 2008
The court was told Carroll did so, but returned later with a second injection, this time containing morphine. Ms Wooldridge told the court Carroll injected ...
Drug-related deaths hit new high in Utah
Salt Lake Tribune, United States - Jul 30, 2008
Oxycodone, morphine and methadone were found in more victims than any other drugs, according to the medical examiner's data. It does not indicate whether ...
Source: Google News

… dose and time profiles of morphine and codeine in plasma, saliva, urine, and beard compared to drug -
EJ Cone - J Anal Toxicol, 1990 - ncbi.nlm.nih.gov
... Both morphine and codeine appeared in beard approximately 7-8 days after drug
administration at a time when drug levels in urine, plasma, and saliva were not ...

mu-Opioid receptor desensitization by bold beta-arrestin-2 determines morphine tolerance but not … -
LM Bohn, RR Gainetdinov, FT Lin, RJ Lefkowitz, MG … - Nature, 2000 - palgrave-journals.com
... 100% [(drug response time - basal response time)/ (30 s - basal response time)] = %
MPE. Twenty-four hours after the 100 mg per kg morphine treatment, both ...

Evidence from rats that morphine tolerance is a learned response.
S Siegel - J Comp Physiol Psychol, 1975 - ncbi.nlm.nih.gov
... of morphine if tolerance is to be observed, (b) a hyperalgesic conditioned response
may be observed in morphine-tolerant subjects when drug administration cues ...

… and ventilatory effects of the morphine metabolites: morphine-6-glucuronide and morphine-3- … -
QL Gong, T Hedner, J Hedner, R Bjorkman, G … - Eur J Pharmacol, 1991 - ncbi.nlm.nih.gov
... Based on calculated ED50 values, morphine-6-glucuronide was approximately 200 times
more potent that morphine itself in the tail-flick and hot-plate tests. ...

Evaluation of the discriminative effects of morphine in the rat.
HE Shannon, SG Holtzman - J Pharmacol Exp Ther, 1976 - ncbi.nlm.nih.gov
... by morphine were further characterized by evaluating the capacity of prototypes
of other classes of psychoactive drugs to produce morphine-like discriminative ...

Antinociceptive activity of clonidine and its potentiation of morphine analgesia.
TC Spaulding, S Fielding, JJ Venafro, H Lal - Eur J Pharmacol, 1979 - ncbi.nlm.nih.gov
... tail flick assay. In this assay, clonidine was found to be 10 times more potent
than morphine. Clonidine potentiated morphine antinociceptive ...

Cognitive performance, mood and experimental pain before and during morphine-induced analgesia in … -
J Lorenz, H Beck, B Bromm - Pain, 1997 - ncbi.nlm.nih.gov
... changes due to treatment with oral sustained-release morphine in six ... A standard auditory
oddball task provided reaction time (RT), errors, N1 and P2 of late ...

THE EVALUATION OF THE ANALGESIC ACTION OF PETHIDINE HYDROCHLORIDE (DEMEROL)
G WOOLFE, AD MACDONALD - Journal of Pharmacology and Experimental Therapeutics, 1944 - ASPET
... that the drug had a marked analgesic effect in dogs ... found it to be five to ten times
as effective ... pethidine with codeine and morphine on human subjects, using ...
-

… urine as an indicator of recent heroin exposure; drug and assay considerations and detection times. -
EJ Cone, P Welch, JM Mitchell, BD Paul - J Anal Toxicol, 1991 - ncbi.nlm.nih.gov
... exposure; drug and assay considerations and detection times. ... Center, National Institute
on Drug Abuse, Baltimore ... acetylmorphine (6-AM), free morphine, and total ...

The safety and efficacy of oral methylnaltrexone in preventing morphine-induced delay in oral-cecal … -
MD Chun-Su Yuan, JF Foss, J Osinski, AT ScD, MF … - Clinical Pharmacology & Therapeutics, 1997 - nature.com
... morphine alone), and a dose-dependent response was obtained. There was no correlation
between oral methylnaltrexone effects on the transit time and the drug ...

Source: Google Scholar
 
 

FDA approves synthetic drug 1,000 times stronger than morphine

  WASHINGTON — A synthetic form of a sea-snail venom was approved yesterday by the Food and Drug Administration as a novel approach to treating severe, chronic pain.

The drug, called Prialt, was approved for hard-to-treat pain associated with cancer, AIDS and neuropathies. Based on a compound found in the poison of the South Pacific cone snail, it controls pain in an entirely new way — by blocking the calcium channels in nerve cells that transmit pain signals — and may have broad implications for pain management.

Because it is as much as 1,000 times more powerful than morphine, it is considered a last resort for long-suffering patients, rather than a first-line pain medication.

"This drug is very exciting because it's a very potent analgesic but isn't a narcotic," said Richard Rauck, of Wake Forest University Medical Center and the Carolinas Pain Institute. Rauck, an investigator for one of the clinical trials that led to yesterday's FDA approval, said he found the drug to be "effective in almost all types of chronic pain it's been studied in."

What will limit the use of Prialt is that it cannot be taken in pill form. It must be delivered directly into the fluid surrounding the spinal cord, which carries it to the brain without affecting other organs. Because it is so potent, tiny amounts of the drug could be dangerous to the heart and possibly other organs.

 

This drug is for patients in chronic and severe pain who are not getting substantial and meaningful relief with oral opiates or are having unacceptable side effects with them," said Robert Meyer, director of the FDA's Office of Drug Evaluation II.

Nonetheless, Lars Ekman, president of Élan Inc. of Ireland, the drug's maker, said up to 100,000 people in the United States might be helped by the drug.

About 50,000 patients already use devices that pump morphine directly into the spinal column, he said, and many of them may want to try Prialt because opioids can gradually lose their effectiveness. In addition, many patients in severe pain who take pain pills may want to try the spinal-cord route if the drug involved is not an opioid, he said.

"There are thousands of people out there who have pain like a bad toothache all day and night, week after week," Ekman said. "Many of these people have tried morphine, and it either didn't work or made them unable to function."

Prialt is a synthetic form of the venom that the Conus magus snail, which lives in tropical saltwater shallows, uses to stun passing prey.

 
Google
Web www.iconocast.com
 

Prialt, expected to reach the market next month, will come with a "black box" warning — the FDA's strongest warning — regarding its risks, which include hallucinations and even psychosis.

Despite Prialt's limitations, Mary Pat Aardrup, executive director of the National Pain Foundation, a nonprofit education group, called it a "red-letter day" for pain patients. "To have another pain drug in an entirely new class is very exciting and very hopeful."

 

Continue News With: H4 ; H5 ; H6 ; H7 ; H8 ; H9 ; H9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services. Home

 © 2002-2006

Keywords:

Contact Iconocast

Home Page